Algorithm for early diagnosis of hepatocellular carcinoma based on gene pair similarity
The article proposes an algorithm based on intelligent methods for the early diagnosis of hepatocellular carcinoma (HCC), known as liver cancer, which is rated third cause of cancer deaths in the world. Initial diagnosis of HСC is based on laboratory studies, computer tomography and X-ray examination. However, in some cases, identifying cancerous tissues as similar non-cancerous tissues (cirrhotic tissues and normal tissues) made it necessary to perform gene analysis for the diagnosis. To predict HCC based on such numerous, diverse and heterogeneous unstructured data, preference is given to the method of artificial intelligence, i.e., machine learning. It shows the possibility of applying machine learning methods to solve the problem of accurate identification of HCC due to the compatibility of HCC tissues with identical CwoHCC non-cancerous tissues. The technology of gene pair profiling using relevant peer databases is described and the Within-Sample Relative Expression Orderings (REO) technique is used to determine the gene pair’s similarity. The article also presents a new approach based on The Within-Sample Relative Expression Orderings technique for determining the gene pair’s similarity, Incremental feature selection method for feature selection, and Support Vector Machine methods for gene pair classification. The proposed approach constitutes the methodological basis of a decision support system for the early diagnosis of HCC, and the development of such a system may be beneficial for physician decision support in the relevant field
Mammadova, M., Jabrayilova, Z. (2019). Electronic medicine: formation and scientific-theoretical problems. Baku: "Information Technologies" publishing house, 319. Available at: https://ict.az/uploads/files/E-medicine-monograph-IIT-ANAS.pdf
Indhumathy, M., Nabhan, A. R., Arumugam, S. (2018). A Weighted Association Rule Mining Method for Predicting HCV-Human Protein Interactions. Current Bioinformatics, 13 (1), 73–84. doi: https://doi.org/10.2174/1574893611666161123142425
El-Serag, H. B. (2011). Hepatocellular Carcinoma. New England Journal of Medicine, 365 (12), 1118–1127. doi: https://doi.org/10.1056/nejmra1001683
Russo, F. P., Imondi, A., Lynch, E. N., Farinati, F. (2018). When and how should we perform a biopsy for HCC in patients with liver cirrhosis in 2018? A review. Digestive and Liver Disease, 50 (7), 640–646. doi: https://doi.org/10.1016/j.dld.2018.03.014
Budhu, A., Forgues, M., Ye, Q.-H., Jia, H.-L., He, P., Zanetti, K. A. et al. (2006). Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment. Cancer Cell, 10 (2), 99–111. doi: https://doi.org/10.1016/j.ccr.2006.06.016
Guan, Q., Yan, H., Chen, Y., Zheng, B., Cai, H., He, J. et al. (2018). Quantitative or qualitative transcriptional diagnostic signatures? A case study for colorectal cancer. BMC Genomics, 19 (1). doi: https://doi.org/10.1186/s12864-018-4446-y
Singh, A., Pandey, B. (2016). An Efficient Diagnosis System for Detection of Liver Disease Using a Novel Integrated Method Based on Principal Component Analysis and K-Nearest Neighbor (PCA-KNN). International Journal of Healthcare Information Systems and Informatics, 11 (4), 56–69. doi: https://doi.org/10.4018/ijhisi.2016100103
Gorunescu, F., Belciug, S., Gorunescu, M., Badea, R. (2012). Intelligent decision-making for liver fibrosis stadialization based on tandem feature selection and evolutionary-driven neural network. Expert Systems with Applications, 39 (17), 12824–12832. doi: https://doi.org/10.1016/j.eswa.2012.05.011
Calderaro, J., Seraphin, T. P., Luedde, T., Simon, T. G. (2022). Artificial intelligence for the prevention and clinical management of hepatocellular carcinoma. Journal of Hepatology, 76 (6), 1348–1361. doi: https://doi.org/10.1016/j.jhep.2022.01.014
Mammadova, M., Bayramov, N., Jabrayilova, Z. (2021). Development of the principles of fuzzy rule-based system for hepatocelular carcinoma staging. EUREKA: Physics and Engineering, 3, 3–13. doi: https://doi.org/10.21303/2461-4262.2021.001829
Mammadova, M. G., Bayramov, N. Y., Jabrayilova, Z. G., Manafli, M. I., Huseynova, M. R. (2022). Knowledge transformation in the intelligent system for hepatocellular carcinoma staging. 8th Conference on Control and Optimization with Industrial Applications-COIA’2022. Azerbaijan, 318–320.
Zhang, Z.-M., Tan, J.-X., Wang, F., Dao, F.-Y., Zhang, Z.-Y., Lin, H. (2020). Early Diagnosis of Hepatocellular Carcinoma Using Machine Learning Method. Frontiers in Bioengineering and Biotechnology, 8. doi: https://doi.org/10.3389/fbioe.2020.00254
Tang, W., Wan, S., Yang, Z., Teschendorff, A. E., Zou, Q. (2017). Tumor origin detection with tissue-specific miRNA and DNA methylation markers. Bioinformatics, 34 (3), 398–406. doi: https://doi.org/10.1093/bioinformatics/btx622
Cao, R., Wang, Z., Wang, Y., Cheng, J. (2014). SMOQ: a tool for predicting the absolute residue-specific quality of a single protein model with support vector machines. BMC Bioinformatics, 15 (1). doi: https://doi.org/10.1186/1471-2105-15-120
Manavalan, B., Basith, S., Shin, T. H., Choi, S., Kim, M. O., Lee, G. (2017). MLACP: machine-learning-based prediction of anticancer peptides. Oncotarget, 8 (44), 77121–77136. doi: https://doi.org/10.18632/oncotarget.20365
Meng, C., Jin, S., Wang, L., Guo, F., Zou, Q. (2019). AOPs-SVM: A Sequence-Based Classifier of Antioxidant Proteins Using a Support Vector Machine. Frontiers in Bioengineering and Biotechnology, 7. doi: https://doi.org/10.3389/fbioe.2019.00224
👁 106 ⬇ 75
Copyright (c) 2022 Zarifa Jabrayilova, Lala Garayeva
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our journal abides by the Creative Commons CC BY copyright rights and permissions for open access journals.
Authors, who are published in this journal, agree to the following conditions:
1. The authors reserve the right to authorship of the work and pass the first publication right of this work to the journal under the terms of a Creative Commons CC BY, which allows others to freely distribute the published research with the obligatory reference to the authors of the original work and the first publication of the work in this journal.
2. The authors have the right to conclude separate supplement agreements that relate to non-exclusive work distribution in the form in which it has been published by the journal (for example, to upload the work to the online storage of the journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this journal is included.